Showing results (1811-1820 of 2,037) with videos related to
Sort By:
Pageof 204
The Neurologist|February 2, 2023
CGRP, Migraine, and Brain MRI in CADASIL: A Pilot StudyEric D Goldstein, Neethu Gopal, Mohammed K Badi, et al.Journal of Inorganic Biochemistry|April 28, 2016
Pervanadate induces Mammalian Ste20 Kinase 3 (MST3) tyrosine phosphorylation but not activationWei-Chih Kan, Te-Ling Lu, Pin Ling, et al.Epidemiology and Infection|January 29, 2002
Hepatitis C virus infection among teenagers in an endemic township in Taiwan: epidemiological and clinical follow-up studiesJ F Huang, S N Lu, P Y Chue, et al.Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|December 28, 2021
[Study on the etiological characteristics and prevention and control of adult community-acquired pneumonia in hospitalized patients in a hospital in Beijing from 2015 to 2019]M Wang, J Y Zhao, X Li, et al.Biomaterials Science|September 15, 2021
<i>peri</i>-Adventitial delivery of smooth muscle cells in porous collagen scaffolds for treatment of experimental abdominal aortic aneurysmJoscha Mulorz, Mahdis Shayan, Caroline Hu, et al.The Kaohsiung Journal of Medical Sciences|November 24, 1999
Evaluation of serum CA27.29, CA15-3 and CEA in patients with breast cancerM F Hou, Y L Chen, T F Tseng, et al.Immunity|December 16, 2011
Control of B cell development by the histone H2A deubiquitinase MYSM1Xiao-Xia Jiang, Quan Nguyen, YuChia Chou, et al.Rheumatology (Oxford, England)|November 17, 2005
Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activityC-H Chen, K-C Lin, D T Y Yu, et al.Alimentary Pharmacology & Therapeutics|February 13, 2009
Bacterial infection and neutropenia during peginterferon plus ribavirin combination therapy in patients with chronic hepatitis C with and without baseline neutropenia in clinical practiceJ-F Yang, M-Y Hsieh, N-J Hou, et al.Leukemia|July 19, 2014
Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10Y Peng, X Chen, Q Liu, et al.Pageof 204